Spat over WHOIS access escalates as FDA hits back at ICANN response
The US Food and Drug Administration has highlighted struggles obtaining responses from registries and registrars when seeking registrant data.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the WTR experts.